India clindamycin HCL market is expected
to grow at a steady rate during the forecast period. The India clindamycin HCL
market is driven by the widespread use of the medication in treatment of
serious infections caused by anaerobic
bacteria’s such as intrabdominal infections, skin infections, among others. Additionally,
clindamycin is used in combination with other antibacterial agents against a
wide range of gram negative bacteria. This in turn is expected to increase the demand for
clindamycin thereby fueling the market growth through FY2026. Furthermore, clindamycin
is used in patients allergic to penicillin. This in turn is expected to
positively influence the market growth over the next few years.
The India clindamycin HCL market is
segmented based on route of administration, source, form, distribution channel,
application, company and region. Based on route of administration, the market
can be split into oral and intravenous.
The oral route is expected to dominate the market owing to the associated
benefits such as self-administration, patient compliance, cost effectiveness,
among others. Additionally, after consumption through oral route the absorption
takes along the whole length of GI tract.
The major players operating in the India
clindamycin HCL market are Midas Pharma India Private Limited, Baxter
Pharmaceuticals India Pvt. Ltd., Fresenius Kabi India Private Limited, Merck
India Pvt. Ltd., Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals
Ltd., Glenmark Pharmaceuticals Limited, Abbott India Limited, GlaxoSmithKline
Pharmaceuticals Ltd., Viraj Pharmaceuticals Pvt. Ltd. and others. Major
companies are developing advanced technologies, receiving approvals from
regulatory bodies and launching new products in order to stay competitive in the market. Other competitive Go-To-Market
strategies include mergers & acquisitions, portfolio enhancement and new product
developments.
Years considered
for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of India clindamycin HCL market
from FY2016 to FY2019.
- To estimate and forecast the market size of India clindamycin HCL market
from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India clindamycin HCL market based on route
of administration, source, form, distribution channel, application, company
and regional distribution.
- To identify dominant region or segment in the India clindamycin HCL
market.
- To identify drivers and challenges for India clindamycin HCL market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India clindamycin HCL market.
- To identify and analyze the profile of leading players operating in
India clindamycin HCL market.
- To identify key sustainable strategies adopted by market players in
India clindamycin HCL market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of India clindamycin HCL market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Clindamycin HCL manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
clindamycin HCL
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India clindamycin HCL market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Clindamycin HCL Market, By Route of Administration:
- India Clindamycin HCL Market, By Source:
- In-House
- Contract
Manufacturing Organizations
- India Clindamycin HCL Market, By Form:
- Tablet
- Capsule
- Injection
- Others
- India Clindamycin HCL Market, By Distribution Channel:
- India Clindamycin HCL Market, By Application:
- Bacterial
Infections
- Skin and
Soft Tissue Infections
- Respiratory
Tract Infections
- Lung
Infections
- Others
- India Clindamycin HCL Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India clindamycin HCL market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Clindamycin HCL market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]